Infinity Pharmaceuticals

(OTC) INFIQ

Current Price$0.00

Market Cap$100

Since IPO (2006)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Infinity Pharmaceuticals Financials at a Glance

Market Cap

$100

Revenue (TTM)

$2.57M

Net Income (TTM)

$40.95M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

116.88 (High)

Dividend

$0.00

Beta (Volatility)

116.88 (High)

Price

$0.00

Volume

222

Open

$0.00

Price

$0.00

Volume

222

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

116.88 (High)

Price

$0.00

Volume

222

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

INFIQ News

Gloved and masked medical researchers using microscopes in their work

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Infinity Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Adelene Q. Perkins, MBA

Website

www.infi.com

Headquarters

Cambridge, US

INFIQ Financials

Key Financial Metrics (TTM)

Gross Margin

40%

Operating Margin

-17%

Net Income Margin

-17%

Return on Equity

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

90.76M

Volume

222

Avg. Volume

4.71K

Financials (TTM)

Gross Profit

$1.03M

Operating Income

$44.84M

EBITDA

$43.73M

Operating Cash Flow

$42.43M

Capital Expenditure

$17.00K

Free Cash Flow

$42.45M

Cash & ST Invst.

$38.31M

Total Debt

$48.13M

Infinity Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2023YOY CHG

Revenue

$583.00K

N/A

Gross Profit

$231.00K

N/A

Gross Margin

39.62%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$3.33

N/A

Employees

N/A

Net Income

$9.96M

N/A

EBITDA

$9.80M

N/A

Quarterly Fundamentals

Name

Q2 2023YOY CHG

Net Cash

$17.11M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$633.00K

N/A

Return on Assets

-1.05%

N/A

Return on Invested Capital

-1.57%

N/A

Free Cash Flow

$8.01M

N/A

Operating Cash Flow

$8.01M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EVLOEvelo Biosciences, Inc.

EVLOEvelo Biosciences, Inc.$0.00+0.00%

LIFSLife Stem Genetics Inc.

LIFSLife Stem Genetics Inc.$0.00+0.00%

ICCTiCoreConnect Inc.

ICCTiCoreConnect Inc.$0.00+0.00%

BTAXBiostax Corp.

BTAXBiostax Corp.$0.00+0.00%

ARDSAridis Pharmaceuticals, Inc.

ARDSAridis Pharmaceuticals, Inc.$0.00-93.44%

AFIBAcutus Medical, Inc.

AFIBAcutus Medical, Inc.$0.00+0.00%

TRVNTrevena, Inc.

TRVNTrevena, Inc.$0.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

POETPoet Technologies

POETPoet Technologies$10.95+0.14%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

Questions About INFIQ

What is the current price of Infinity Pharmaceuticals?

Infinity Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Infinity Pharmaceuticals?

Over the past 52 weeks, Infinity Pharmaceuticals has traded between N/A and $0.00.

How much debt does Infinity Pharmaceuticals have?

As of the most recent reporting period, Infinity Pharmaceuticals reported total debt of $49.35M.

How much cash does Infinity Pharmaceuticals have on hand?

Infinity Pharmaceuticals reported $38.31M in cash and cash equivalents in its most recent financial results.

What is Infinity Pharmaceuticals’s dividend yield?

Infinity Pharmaceuticals does not currently have a dividend yield.

Infinity Pharmaceuticals

Infinity Pharmaceuticals Financials at a Glance

INFIQ News

Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today

Why Infinity Pharmaceuticals Is Skyrocketing Today

What Investors Missed in the Stock Market Last Week

Why Infinity Pharmaceuticals Inc. Is Being Obliterated Today

Infinity Pharmaceuticals' Stock Dipped 15% in July: Time to Buy?

Why Infinity Pharmaceuticals Inc. Stock Skyrocketed

Why InterMune, Zulily, and Infinity Pharmaceuticals Are Today's 3 Best Stocks

Why Infinity Pharmaceuticals Inc. Shares Jumped

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Infinity Pharmaceuticals

INFIQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Infinity Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INFIQ

What is the current price of Infinity Pharmaceuticals?

What is the 52-week range for Infinity Pharmaceuticals?

How much debt does Infinity Pharmaceuticals have?

How much cash does Infinity Pharmaceuticals have on hand?

What is Infinity Pharmaceuticals’s dividend yield?

Premium Investing Services